Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 3 de 3
Filter
Add more filters











Database
Language
Publication year range
1.
Int J Oral Maxillofac Surg ; 52(5): 515-523, 2023 May.
Article in English | MEDLINE | ID: mdl-36123273

ABSTRACT

The aim of this study was to clarify the correlation between imaging findings obtained using intraoral ultrasonography (US) and pathological findings of tongue cancers, and to examine the predictive value of intraoral US findings with respect to occult nodal metastasis. This was a retrospective study based on the medical records of 123 patients with T1-2N0 tongue cancer. The depth of invasion (DOI) on intraoral US was positively correlated with the pathological invasion depth (PID) (ρ = 0.7080, P < 0.0001). Receiver operating characteristic analyses revealed an optimal DOI cut-off value of 4.1 mm and optimal PID cut-off value of 3.9 mm to detect nodal metastasis. Regarding the margin shape of the primary tumour on intraoral US, the incidence of nodal metastasis was significantly higher for the permeated type than for the pressure type (P < 0.001) and wedge-shaped type (P = 0.002). Furthermore, tumours with peritumoural vascularity assessed by power Doppler US had a significantly higher incidence of nodal metastasis than tumours without (P = 0.003). The sensitivity, specificity, and accuracy of the permeated type to predict nodal metastasis was 53.6%, 95.8%, and 86.2%, respectively. These results suggest that intraoral US findings closely reflect pathological findings and could be useful to predict occult nodal metastasis in patients with early-stage tongue cancer.


Subject(s)
Tongue Neoplasms , Humans , Tongue Neoplasms/diagnostic imaging , Retrospective Studies , Tongue , Angiography , Transforming Growth Factor beta , Ultrasonography
2.
Int J Oral Maxillofac Surg ; 50(2): 163-170, 2021 Feb.
Article in English | MEDLINE | ID: mdl-32536459

ABSTRACT

Protease-activated receptor 1 (PAR1) is known as a thrombin receptor. Recent studies have reported PAR1 expression in various malignancies; however, its role in oral squamous cell carcinoma (OSCC) requires clarification. A previous study showed that down-regulation of ΔNp63, a homolog of p53, augments PAR1 expression in OSCC. In the present study, the association of PAR1 expression with clinicopathological findings in OSCC was examined retrospectively. Expression of PAR1, thrombin, and ΔNp63 was examined immunohistochemically in OSCC specimens. Patients were divided into three groups based on the expression pattern of PAR1 at the invasive front: group A, PAR1-negative in both cancer and stromal cells; group B, positive in stromal cells but negative in cancer cells; group C, positive in both cancer and stromal cells. Histologically high-grade tumours were significantly more common in group C. Patients in group C had the highest incidence rate of nodal metastasis (P<0.001) and a lower survival rate (P=0.085) than those in the other groups. At the invasive front, in group C, thrombin was expressed but ΔNp63 expression was weak. These results indicate that increased PAR1 expression in both cancer and stromal cells could be a useful predictive marker of nodal metastasis and that ΔNp63 is involved in regulating PAR1 expression.


Subject(s)
Carcinoma, Squamous Cell , Head and Neck Neoplasms , Mouth Neoplasms , Down-Regulation , Humans , Receptor, PAR-1/genetics , Receptor, PAR-1/metabolism , Retrospective Studies , Squamous Cell Carcinoma of Head and Neck
3.
J Neurol Neurosurg Psychiatry ; 56(6): 713-6, 1993 Jun.
Article in English | MEDLINE | ID: mdl-8509793

ABSTRACT

The rare association of two neurological paraneoplastic syndromes, paraneoplastic cerebellar degeneration and limbic encephalitis occurred in a 55 year old woman with a microscopic adenocarcinoma in a colonic polyp. Complete removal of the tumour by polypectomy brought about a favourable recovery from limbic encephalitis but the cerebellar ataxia remained. High titres of antineuronal nuclear antibody resembling anti-Hu were demonstrated in serum by immunohistochemistry using rat brain as a substrate. The antibody identified a protein band of 41 kDa on a Western immunoblot.


Subject(s)
Adenocarcinoma/complications , Cerebellar Ataxia/complications , Colonic Neoplasms/complications , Encephalitis/complications , Limbic System/pathology , Paraneoplastic Syndromes/complications , Blotting, Western , Brain/pathology , Cerebellar Ataxia/metabolism , Encephalitis/metabolism , Female , Humans , Immunoenzyme Techniques , Limbic System/chemistry , Magnetic Resonance Imaging , Middle Aged , Paraneoplastic Syndromes/metabolism
SELECTION OF CITATIONS
SEARCH DETAIL